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Identification of DC-SIGN, a Novel Dendritic
Cell±Specific ICAM-3 Receptor that Supports
Primary Immune Responses
efficient T cell activation (Hernandez-Caselles et al.,
1993). Indeed, antibody engagement of ICAM-3 results
in elevation of intracellular calcium levels and induction
of tyrosine phosphorylation (Juan et al., 1994).
The b2 integrins LFA-1 (aLb2) and aDb2 have both
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University Medical Center St. Radboud been described as the primary receptors for ICAM-3,
although the affinity of both integrins for ICAM-3, evenPhilips van Leydenlaan 25
Nijmegen 6525 EX after integrin activation (Dustin and Springer, 1989; van
Kooyk et al., 1989), is rather low (Binnerts et al., 1994;The Netherlands
Vandervieren et al., 1995). Because LFA-1 is expressed
by DC and anti-LFA-1 antibodies partially inhibit DC±T
cell interactions (Hauss et al., 1995; Starling et al., 1995),Summary
it potentially mediates binding of resting T cells through
ICAM-3. However, the multitude of adhesion receptorsContact between dendritic cells (DC) and resting T cells
is essential to initiate a primary immune response. Here, and ligands that simultaneously contribute to the DC±T
cell contacts form a major obstacle in antibody blockingwe demonstrate that ICAM-3 expressed by resting T
cells is important in this first contact with DC. We studies to dissect the individual role of each adhesion
receptor. To circumvent this problem, we developeddiscovered that instead of the common ICAM-3 re-
ceptors LFA-1 and aDb2, a novel DC-specific C-type an adhesion assay (Geijtenbeek et al., 1999) in which
fluorescent beads coated with ICAM-3 allow us to spe-lectin, DC-SIGN, binds ICAM-3 with high affinity.
DC-SIGN, which is abundantly expressed by DC both cifically address the role of ICAM-3 in DC±T cell interac-
tions. Here, we report that neither LFA-1 nor aDb2 butin vitro and in vivo, mediates transient adhesion with
T cells. Since antibodies against DC-SIGN inhibit DC- a novel ICAM-3 binding C-type lectin, exclusively ex-
pressed by DC, mediates strong adhesion between DCinduced proliferation of resting T cells, our findings
predict that DC-SIGN enables T cell receptor engage- to ICAM-3 on resting T cells and is essential for DC-
induced T cell proliferation.ment by stabilization of the DC±T cell contact zone.
ResultsIntroduction
Adhesion of DC to ICAM-3 Is Mediated by DC-SIGNDendritic cells (DC) are professional antigen-presenting
The extremely high expression of ICAM-3 compared tocells that efficiently capture antigens in the peripheral
ICAM-1 on resting T cells led us to hypothesize thattissues and process these antigens to form MHC±
ICAM-3-mediated adhesion might be crucial in DC±Tpeptide complexes. After antigen uptake, these imma-
cell interactions. Exploiting a recently developed flowture DC acquire the unique capacity to migrate from the
cytometric adhesion assay (Geijtenbeek et al., 1999), weperiphery to the T cell areas of secondary lymphoid
tested the capacity of immature DC and monocytes toorgans. As the cells travel, they mature and alter their
bind to fluorescent beads coated with ICAM-3-Fc. DCprofile of cell surface molecules, to attract resting T
strongly bind to ICAM-3 when compared to monocytescells and present their antigenic load (Shaw et al., 1986;
(Figure 1A). Whereas ICAM-3 binding by monocytes isAdema et al., 1997; Banchereau and Steinman, 1998).
for the greater part LFA-1 mediated, since both anti-How the initial contact between DC and resting T
LFA-1 (aL) and anti-b2 integrin antibodies significantlycells, necessary for T cell activation, is established and
inhibit adhesion of monocytes to ICAM-3, binding ofregulated is still largely unknown. Early studies indicated
ICAM-3 by DC is completely LFA-1 independent (Figurethat DC and T cells tend to form clusters in an antigen-
1A). This integrin-independent binding is further sub-independent manner (Steinman and Cohn, 1974). Both
stantiated by the findings that neither antibodies di-adhesion and costimulatory molecules with their corre-
rected against the other b2 integrins (aD, aM, aX, datasponding ligands, such as LFA-3/CD2 and LFA-1/ICAM-1,
not shown) nor antibodies directed against b subunits-2 or -3, are potential candidates to mediate these
of other integrins (b1, b2, b3, b4, and b7, Figure 1B;DC±T cell interactions (Springer et al., 1987; Hauss et
data not shown) can inhibit ICAM-3 binding by DC. Inter-al., 1995; Starling et al., 1995). Several studies have
estingly, though the interaction is integrin independentsuggested that binding of LFA-1 to ICAM-3, which is
it requires the presence of Ca21, as both EDTA and EGTAexpressed at high levels on resting T cells, might be
are inhibitory (Figure 1B). The specificity of this adhesionimportant in establishing these initial DC±T cell interac-
receptor on DC for ICAM-3 is demonstrated by the abilitytions (Vilella et al., 1990; de Fougerolles and Springer,
of the antibodies against ICAM-3 to inhibit binding (Fig-1992; Hauss et al., 1995; Starling et al., 1995). Separate
ure 1B). From these observations, we concluded that DCfrom mediating adhesion between DC and T cells, ICAM-3
interact with ICAM-3 through an integrin-independentmay be important in providing signals necessary for
mechanism that requires Ca21. We designated this re-
ceptor DC-specific ICAM-3 grabbing nonintegrin (DC-* To whom correspondence should be addressed (e-mail: y.vankooyk@
dent.kun.nl). SIGN).
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expressed this protein in human placenta were not iden-
tified (Curtis et al., 1992).
RT-PCR analysis of RNA isolated from DC with prim-
ers based on the gp120-binding C-type lectin sequence
yielded a PCR product of the expected length of 1237
nucleotides. Subsequent nucleotide sequence analysis
confirmed that DC-SIGN is identical to the HIV-1 gp120
binding C-type lectin (data not shown). DC-SIGN is a
type II transmembrane protein consisting of 404 amino
acids with three distinct domains. The N-terminal cyto-
plasmic domain of 40 amino acid residues is separated
by a hydrophobic stretch of 15 amino acids from a region
that consists of seven complete and one incomplete
tandem repeat of nearly identical sequence. The extra-
cellular C-terminal region (Cys253-Ala404) shows ho-
mology to Ca21-dependent (C-type) lectins (Figure 2C).
To prove that DC-SIGN is indeed an ICAM-3 recep-
tor, we transiently transfected COS7 cells with cDNA
encoding DC-SIGN. Flow cytometric analysis of these
transfectants unequivocally proves that this cDNA en-
codes for DC-SIGN (Figure 2D, inset). About 30% of
the COS7 cells stained with anti-DC-SIGN antibody and
therefore expressed DC-SIGN. Moreover, the COS7 cells
expressing DC-SIGN strongly bind ICAM-3, whereas
mock transfected COS7 cells do not (Figure 2D). As
expected, binding of ICAM-3-coated beads by COS7-Figure 1. Adhesion of Immature DC to ICAM-3 Is Ca21 Dependent
DC-SIGN cells is Ca21 dependent and can be inhibitedand Integrin Independent
by antibodies against ICAM-3 or DC-SIGN (Figure 2D).(A) Spontaneous adhesion of peripheral blood leukocytes (PBL),
Similar results were obtained with hematopoietic cellsmonocytes, and immature DC to ICAM-3. LFA-1- and b2 integrin-
specific adhesion was determined in the presence of blocking mAb when transfected with the DC-SIGN cDNA. Stable ex-
(20 mg/ml) against LFA-1 (NKI-L15) and b2 integrins (AZN-L19). pression of DC-SIGN by the erythroleukemic cell line
(B) Adhesion of immature DC to ICAM-3 in the presence of blocking K562 as well as the promonocytic cell line THP-1 re-
mAb (20 mg/ml) against b2 integrins (b2 chain, AZN-L19), b1 integrins
sulted in strong binding of ICAM-3 (data not shown).(b1 chain, AIIB2), and ICAM-3 (CBR-IC3/1, CBR-IC3/2) and in the
Since both DC-SIGN and LFA-1 bind ICAM-3, we stud-presence of EDTA (5 mM) or EGTA (5 mM). In (A) and (B), one
ied their relative binding affinity for soluble ICAM-3 (Fig-representative experiment out of three is shown (SD , 5%).
ure 3A) (Yauch et al., 1997; van Kooyk et al., 1999). DC-
SIGN strongly binds soluble ICAM-3 with an IC50 of 7
mg/ml ICAM-3Fc. In contrast, LFA-1 is not active on DCDC-SIGN Is a 44 kDa Protein Identical to the HIV-1
and therefore does not bind ICAM-3 (Figure 1), even atgp120 Binding C-Type Lectin
high concentrations of ICAM-3 (Figure 3A). This cannotTo characterize DC-SIGN in more detail, we raised
be attributed to low expression levels of LFA-1 on DCmonoclonal antibodies against this novel ICAM-3 adhe-
since HSB T cells, which express similar levels of ansion receptor. Two hybridomas, AZN-D1 and AZN-D2,
active form of LFA-1 (Binnerts and van Kooyk, 1999),were isolated. Antibodies secreted by both hybridomas
readily bind ICAM-3 (Figure 3A, IC50 5 15 mg/ml).strongly inhibit adhesion of DC to ICAM-3 (Figure 2A)
As DC-SIGN is a C-type mannose-binding lectin (Cur-This, together with the observation that both antibodies
tis et al., 1992; Weis et al., 1998) containing a CRDdo not affect LFA-1-mediated adhesion of monocytes
motif that binds two Ca21 ions and mannose (Drickamer,to ICAM-3, suggests that these antibodies are specific
1995), we investigated whether Ca21 cations and carbo-for DC-SIGN (Figure 2A).
hydrates contribute to the recognition of ICAM-3 by DC-SDS-PAGE analysis of immunoprecipitated DC-SIGN
SIGN. Titration of Ca21 concentrations demonstratedfrom a 125I-surface-labeled DC lysate revealed that DC-
that the concentration around 0.3 mM Ca21 gave maxi-SIGN is a single protein of 44 kDa (Figure 2B). After
mal ICAM-3 binding (second order Calcium binding) inexcision of this 44 kDa band from the SDS-PAGE gel,
accordance to other C-type lectins (Figure 3B) (Mullinthe amino acid sequence of two peptides (0.5±1 pmol)
et al., 1997). Other bivalent cations were not capable ofwas deduced (Edman degradation procedure). The pep-
mediating ligand binding. Inhibition studies using seriestides consisted of 12 and 14 amino acid residues, re-
of saccharides demonstrated that mannan is the mostspectively, and 11 amino acid residues of both peptides
potent carbohydrate inhibitor (Figure 3C) (IC50 5 1 mM)were identified (Figure 2C). Both peptide sequences
and blocks ICAM-3 binding as efficiently as anti-DC-SIGNproved 100% identical to the deduced amino acid se-
antibodies. Similarly, D(1)-mannose inhibits ICAM-3 ad-quence of the HIV-1 envelope glycoprotein gp120 bind-
hesion although with lower affinity than mannan. Theseing C-type lectin (Curtis et al., 1992). This protein was
data suggest that ICAM-3 binding by DC-SIGN dependscloned from a human placenta cDNA library and re-
on binding of two Ca21 and is at least partially dependentported to be a CD4-independent receptor for binding of
the HIV-1 envelope glycoprotein gp120. The cells that on mannose moieties.
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Figure 2. Molecular Characterization of DC-SIGN
(A) Anti-DC-SIGN mAb AZN-D1 and AZN-D2 (20 mg/ml) block adhesion of immature DC but not that of freshly isolated monocytes to ICAM-
3Fc-coated fluorescent beads. Adhesion of monocytes to ICAM-3 is blocked by anti-b2 integrin mAb (AZN-L19, 20 mg/ml). A representative
experiment out of three experiments is shown (SD , 5%).
(B) DC-SIGN is a 44 kDa protein. DC were surface labeled with I125 and lysed, and DC-SIGN was immunoprecipitated with anti-DC-SIGN
antibodies AZN-D1 (lane 1) and AZN-D2 (lane 2). The b2 integrin chain and the a chains (aL, aM, and aX) were immunoprecipitated with
AZN-L19 (anti-b2 integrin; lane 3). The immunoprecipitates were analyzed by SDS-PAGE (5%±15% gel, reduced conditions) followed by
autoradiography. The migration of the molecular weight markers is indicated on the left. The arrows indicate the a chains of LFA-1 (aL, 180
kDa), MAC-1 (aM, 165 kDa) and p150,95 (aX, 150 kDa), the b2 integrin chain (95 kDa), and DC-SIGN (44 kDa). Similar results were obtained
in three other experiments.
(C) Schematic presentation of DC-SIGN isolated from human DC. Immature DC were lysed (1% Nonidet-40), and analysis of the immunoprecipi-
tates, performed with anti-DC-SIGN mAb, revealed a protein of 44 kDa. After immunoprecipitation (B), the protein was excised from the gel,
and tryptic peptides were sequenced. The two boxed peptide sequences were identified (corresponding to amino acid positions 187±197
and 296±306 of the human placenta gp120 binding C-type lectin [Curtis et al., 1992]). The nucleotide sequence encoding DC-SIGN is 100%
identical to that of the human placenta gp120 binding C-type lectin. The transmembrane region (TM), the C-type lectin domain, and the seven
complete and one partial repeat (R1-R8) are indicated.
(D) Adhesion of COS7 cells, transiently transfected with DC-SIGN, to ICAM3. Anti-DC-SIGN antibodies (AZN-D1) recognize COS7 cells
transfected with the cDNA encoding DC-SIGN (filled histogram, 30% positive cells as determined by flow cytometry, see inset). Mock transfected
cells (open histogram, see inset) are not stained. Adhesion of COS7DC-SIGN cells to ICAM-3 was measured in the presence of EGTA (5 mM)
and blocking antibodies against DC-SIGN (AZN-D1), ICAM-3 (CBR-IC3/1, CBR-IC3/2), or b2 integrins (AZN-L19). Adhesion was determined
as described in Figure 1. A representative experiment out of three is shown (SD , 5%).
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DC-SIGN Expression Is DC Specific
Differentiation of monocytes into immature DC in vitro
in the presence of GM-CSF and IL-4 coincides with DC-
SIGN expression at extremely high levels (Figure 4A).
Expression is already observed from day 1 onward (Fig-
ure 4A). Expression gradually increases in time, in con-
trast to the expression of LFA-1, which remains unal-
tered (Figure 4A). In accordance with literature (Sallusto
and Lanzavecchia, 1994), expression of the monocyte
marker CD14 decreases during culture, and at day 7
only low CD14 expression is observed on DC (Figure
4A). Further phenotypic analyses demonstrate that at
day 7 the cells express high levels of ICAM-1, aMb2,
aXb2, MHC class I and II, and moderate levels of CD86
(data not shown), consistent with the phenotype of im-
mature DC (Romani et al., 1994; Sallusto and Lanzavec-
chia, 1994). Further maturation of DC in the presence
of cytokines (TNF, IL-1, or LPS) did not significantly
enhance DC-SIGN expression (data not shown). Besides
monocyte-derived DC, DC-SIGN is also expressed by
DC obtained from other DC precursors such as bone
marrow CD341 cells (data not shown). Together, these
results demonstrate that DC generated in vitro abun-
dantly express DC-SIGN at day 7 and that expression
of DC-SIGN is several fold higher than that of LFA-1.
Also, the expression level of DC-SIGN correlates with
DC-SIGN-mediated adhesion of DC to ICAM-3 (Figure
4B). Further flow cytometric analysis of an extensive
panel of hematopoietic cells with anti-DC-SIGN antibod-
ies demonstrates that DC-SIGN is exclusively expressed
by both immature and mature DC (Table 1). DC-SIGN
is not expressed by monocytes, activated monocytes,
monocytic cell lines, granulocytes, T cells, B cells, acti-
vated B and T cells, thymocytes, and CD341 bone mar-
row cells.
To examine whether DC-SIGN expression in vitro co-
incides with expression in situ, sections of lymph node,
spleen, tonsil, and skin were stained with anti-DC-SIGN
antibodies (Figure 5). DC-SIGN-expressing cells areFigure 3. DC-SIGN-Mediated ICAM-3 Binding
present in the T cell area of both lymph nodes (a and(A) DC-SIGN binds ICAM-3 with higher affinity than LFA-1. Adhesion
of soluble ICAM-3Fc was measured to both immature DC and HSB b), tonsils (c), and spleen (d). These cells are large and
T cells. LFA-1 on the HSB T cells has been activated with anti- very irregular in shape, consistent with the distribution
b2 integrin antibody KIM185. Binding of ICAM-3Fc (30 min room and morphology of DC (Figure 5b). No staining of DC-
temperature) was analyzed by flow cytometry after staining with a
SIGN is observed in germinal centers and mantle zonesFITC-conjugated anti-human Fc antibody. To determine the recep-
of the lymphoid tissues (Figures 5a±5d). Analyses oftors involved in ICAM-3Fc binding, both anti-DC-SIGN and anti-
serial sections stained for CD3, CD20, CD14, and CD68LFA-1 antibodies were used to block adhesion, and the DC-SIGN
and LFA-1-specific adhesion is depicted. A representative experi- confirm that the DC-SIGN-expressing cells are distinct
ment out of three is shown (SD , 5%). from T cells, B cells, monocytes, and macrophages,
(B) DC-SIGN-mediated ICAM-3 binding is Ca21 dependent. Binding respectively (data not shown). In skin sections, DC-SIGN
of DC to ICAM-3Fc-coated beads is measured at different Ca21
is only expressed on dermal DC (Figure 5e), whereasconcentrations in the presence and absence of anti-DC-SIGN anti-
CD1a positive Langerhans cells in the epidermis arebodies (AZN-D1, 20 mg/ml). The resulting curve best fitted to the
negative (Figure 5f). Furthermore, DC-SIGN is expressedequation for second order dependence to Ca21 (fractional binding) 5
[Ca21]2 / ((KCa21)2 1 [Ca21]2), which demonstrates that DC-SIGN on DC-like cells present in the mucosal tissues, such
binds two Calcium ions similarly as has been shown for other C-type as rectum, cervix, and uterus (Geijtenbeek et al., 2000
lectins (Mullin et al., 1997). A representative experiment out of three [this issue of Cell]) and are localized underneath the
is shown.
stratified squamous epithelium in the lamina propria.(C) DC-SIGN-mediated ICAM-3 binding is mediated by carbohy-
From these findings, we conclude that DC-SIGN is spe-drates. Different carbohydrates were used to inhibit the adhesion
cifically expressed by DC both in vitro and in vivo.of DC to ICAM-3Fc beads. As shown, DC-SIGN belongs to the
C-type lectins that can bind mannose-like carbohydrates (Drick-
amer, 1999). A representative experiment out of three is shown. DC-SIGN Mediates DC±T Cell Clustering and
DC-Induced Proliferation of Resting T Cells
A major obstacle in identifying the molecules that partici-
pate in DC±T cell interactions is caused by the multitude
DC-SIGN Is a DC-Specific Adhesion Receptor
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Figure 4. Binding of ICAM-3 Shifts from Integrin Mediated to DC-SIGN Mediated during Development of Monocyte-Derived DC In Vitro
(A) DC-SIGN expression increases during DC development in vitro. Immature DC were cultured from monocytes in the presence of GM-CSF
and IL-4. At different time points, the developing DC were analyzed for expression of the monocyte marker CD14, the b2 integrin LFA-1 (NKI-
L15), and DC-SIGN (AZN-D1). Cells were gated on forward-side scatter, and the mean fluorescence is shown in the top right corner of the
histograms. One representative experiment out of three is shown.
(B) Immature DC developing from monocytes increasingly bind to ICAM-3 in a DC-SIGN-dependent manner. At different time points during
culture, the ICAM-3-specific adhesion was determined in the presence of blocking anti-b2 integrin (AZN-L19) or anti-DC-SIGN (AZN-D1) mAb
(20 mg/ml). Specific adhesion of DC-SIGN and the b2 integrins is calculated from the inhibition of adhesion in the presence of the blocking
mAb AZN-D1 or AZN-L19, respectively. A representative experiment out of three is shown (SD , 5%).
of interactions that contribute simultaneously. In an at- binding to ICAM-3 reaches a maximum at 19 min after
DC±T cell contacts (Figure 6B). Also, LFA-1- and LFA-tempt to evaluate the role of DC-SIGN in this process,
we analyzed the capacity of DC to cluster with ICAM-3 3-mediated DC±T cell clustering is transient and fol-
lowed the kinetics of the DC-SIGN-mediated adhesion,transfectants (K562-ICAM-3). For this purpose, we chose
K562 cells that lack expression of b1 and b2 integrins reaching a maximum at 23 min after initial DC±T cell
contact (Figure 6B).(except a5b1) and only express ICAM-1. The results
in Figure 6A show that DC form clusters with K562- To examine if these DC-SIGN-mediated interactions
are important in the initiation of primary immune re-ICAM-3 in a DC-SIGN-dependent manner since anti-
DC-SIGN antibodies block the interaction. Interestingly, sponses, we tested the capacity of allogeneic DC to
induce proliferation of resting T cells compared to acti-DC-SIGN-dependent clustering is transient, indicating
that DC-SIGN/ICAM-3 interactions are actively regu- vated T cells. As demonstrated in Figure 6C, the pres-
ence of anti-DC-SIGN antibodies inhibit the DC-inducedlated. The gradual increase in DC-SIGN-independent
clustering of DC to untransfected K562 cells is caused proliferation of resting T cells for more than 60%. Simi-
larly to DC±T cell clustering, also here LFA-1 and LFA-3by LFA-1 on DC that binds ICAM-1 on K562 cells (data
not shown). contribute to the DC-induced T cell proliferation, since
antibodies against b2 integrins (LFA-1) and LFA-3 affectTo demonstrate that DC-SIGN/ICAM-3 interactions
are also essential in DC±T cell binding and T cell activa- proliferation as well (Figure 6C). Antibodies against
ICAM-1 inhibited proliferation comparable to antibodiestion, we analyzed the involvement of DC-SIGN in both
DC±T cell clustering and DC-induced T cell proliferation. against b2 integrins whereas anti-ICAM-3 antibodies do
not inhibit proliferation (data not shown), which can beDC cluster efficiently with allogeneic resting T cells
reaching a maximum at 25 min after initial contact (Fig- ascribed to the costimulatory effects of anti-ICAM-3 an-
tibodies in T cell proliferation as was observed pre-ure 6B). The transient nature of this DC±T cell clustering
is not completely DC-SIGN dependent, since also other viously (Delpozo et al., 1994). When anti-LFA-3 and anti-
DC-SIGN antibodies are combined, a complete block ofadhesion molecules, such as LFA-1 and LFA-3, contrib-
ute in stabilizing DC±T cell contact. DC-SIGN-mediated DC-induced T cell proliferation is observed (Figure 6C).
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Banchereau and Steinman, 1998). They possess a supe-Table 1. Expression Level of DC-SIGN on Hematopoietic Cells
as Determined by Flow Cytometric Analyses and RT-PCR rior antigen processing and presentation machinery. In
addition, they are equipped with unique migratory ca-DC-SIGN DC-SIGN
pacities allowing these cells to capture antigen in theCell Type Expressiona mRNAb
periphery and present these to resting/naive T cells that
Monocytes #15 2
reside in the lymphoid organs. Seminal observationsImmature DC day 7 980 1
made in the early seventies (Steinman and Cohn, 1973;Mature DC day 9c
Steinman et al., 1974), showing rosettes of T cells aroundLPS 489 1
MCM/PGE2 445 1 DC, already hinted at the importance of adhesion recep-
TNFa 420 1 tors on DC to facilitate T cell contact.
PBL #15 2
T cells #15 2
DC-SIGN Is a Dendritic Cell±SpecificB cells #15 2
Adhesion ReceptorThymocytes #15 2
Granulocytes #15 2 Here, we have identified a novel DC-specific C-type
CD341 cells #15 ND lectin, DC-SIGN, that mediates the initial contact of DC
PBMC (activatedd) #15 2 with resting T cells. Therefore, the staggering antigen-
T cell linese #15 2
presenting capacity of DC may nowÐin addition to theirMonocytic cell linesf #15 2
unique antigen processing machineryÐat least in part
a Mean fluorescence of staining with AZN-D1. be attributed to their ability to interact with resting T
b RT-PCR with the DC-SIGN-specific primers XF29 and XR1265 on cells through DC-SIGN. Our results demonstrate that
total RNA isolated from the different cells.
DC-SIGN is a major ICAM-3 receptor on DC and essen-c Immature DC were maturated with GM-CSF, IL-4 and either TNFa,
tial in establishing the initial transient DC±T cell contact.LPS or a combination of Monocyte Conditioned Medium (MCM) and
prostaglandin E2. This is supported by the high relative binding affinity of
d Activated with PHA (10 (g/ml) and IL-2 (10 U/ml) for 2 days. DC-SIGN for ICAM-3 when compared to that of LFA-1
e T cell lines: HSB, PEER, CEM and Jurkat. (Figure 3A). Therefore, this C-type lectin, rather than b2
f Monocytic cell lines: THP-1, MM6, and U937. integrins, is the predominant ICAM-3 receptor on DC.
ND, not determined.
Binding of ICAM-3 by DC-SIGN is Ca21 dependent and
can be inhibited by mannose, which is characteristic for
C-type lectins that contain Ca21-dependent extracellular
In contrast, combinations of anti-DC-SIGN antibodies carbohydrate recognition domains (CRDs). DC express
with antibodies against ICAM-1, ICAM-3, or LFA-1 do other C-type lectins, such as the macrophage-mannose
not further reduce the T cell proliferation when com- receptor (MMR) and DEC-205, that bind and internalize
pared with anti-DC-SIGN antibodies alone (data not carbohydrate-bearing antigens by receptor-mediated
shown). endocytosis (Jiang et al., 1995; Sallusto et al., 1995).
The observation that resting T cells express high lev- The finding that C-type lectins are involved in the uptake
els of ICAM-3 and low levels of ICAM-1, compared to and presentation of antigens via DC (Jiang et al., 1995),
activated T cells that express equal amounts of ICAM-3 and the fact that mannosylation of antigen leads to a
and ICAM-1 (de Fougerolles and Springer, 1992; Hauss selective targeting and superior presentation by DC (Tan
et al., 1995; Starling et al., 1995), suggests that DC- et al., 1997), indicates that DC-SIGN as a C-type lectin
SIGN/ICAM-3 interactions are of particular importance may also have an important consequences for antigen
in the activation of resting T cells rather than maintaining presentation by DC.
responses of previously activated T cells. This notion Peptide amino acid sequencing demonstrated that
was supported by the finding that neither anti-DC-SIGN DC-SIGN is identical to the HIV-1 envelope glycoprotein
antibodies nor ICAM-3 antibodies (Figure 6D) or a com- g120 binding C-type lectin cloned from a placental cDNA
bination thereof (data not shown) was capable of inhib- library (Curtis et al., 1992). In the accompanying paper
iting T cell stimulation of activated T cells. These findings (Geijtenbeek et al., 2000), we demonstrate that indeed
demonstrate that DC-induced proliferation of activated DC-SIGN expressed by DC also binds the HIV-1 enve-
T cells is mainly mediated by LFA-3/CD2 with little con- lope glycoprotein gp120. DC, present in initial sites of
tribution of DC-SIGN. HIV-1 infection, efficiently capture HIV-1 through DC-
To exclude the possibility that the effects observed SIGN and facilitate the infection of T cells through a
with anti-DC-SIGN antibodies are caused by altered ex- unique in trans mechanism (Geijtenbeek et al., 2000).
pression of other important surface molecules on DC Both gp120 (Curtis et al., 1992; data not shown) and
such as LFA-1, LFA-3, and MHC class I and II that affect ICAM-3 (Figures 3B and 3C) are bound by DC-SIGN in
cell±cell binding, we analyzed the DC phenotype before a Ca21-dependent mechanism (Figure 3B), and binding
and after exposure to anti-DC-SIGN. No changes were can be inhibited by mannan (Figure 3C), suggesting that
observed in either of the molecules tested (Figure 6E). carbohydrates are involved. This observation and the
Similarly, expression of Mac-1, p150,95, and CD4 is not finding that both gp120 (Geijtenbeek et al., 2000) and
affected by anti-DC-SIGN antibodies (data not shown). ICAM-3-binding of DC can be inhibited by the anti-DC-
SIGN antibodies AZN-D1 and -D2 suggest that ICAM-3
and gp120 bind to similar or closely located sites.Discussion
DC constitutes a heterogeneous population of cells,
which are present at minute numbers in various tissues.DC are the strongest antigen-presenting cells and func-
tion as sentinels of the immune system (Steinman, 1991; To date, several subtypes of DC have been identified,
DC-SIGN Is a DC-Specific Adhesion Receptor
581
Figure 5. DC-SIGN Expression In Vivo Is Restricted to DC
Immunohistochemical analysis of DC-SIGN expression in lymphoid tissue and human skin. Different tissue sections were stained with anti-
DC-SIGN mAb: lymph node (a) and magnification of lymph node (b); tonsil (c); spleen (d; double labeling, CD3 [red] and DC-SIGN [blue]); skin
(e); and Langerhans cells are identified by CD1a antibodies (f). The germinal center (GC), T cell area (T), epidermis (E), and dermis (D) are
depicted. DC-SIGN positive cells are identified in the T cell areas of lymphoid tissues (a-d) and in the dermis of skin (e). Staining of serial
sections demonstrates that these DC-SIGN positive cells do not express CD3, CD20, CD14, and CD68 (data not shown).
including myeloid DC derived from monocytes or CD341 to provide positional stability, thus facilitating TCR en-
gagement (Shaw et al., 1986). TCR triggering subse-bone marrow cells. To better define the different popula-
quently initiates strong adhesive LFA-1-mediated inter-tions, much effort has been spent to generate antibodies
actions, through avidity alterations (Dustin and Springer,that recognize DC lineage-specific cell surface mole-
1989; van Kooyk et al., 1989). Recently, Dustin et al.cules. So far, only a few antibodies are DC specific.
(1998) demonstrated that TCR signaling also leads toThese include DC-CK-1, DC-LAMP, CMRF-44, CMRF-
clustering of CD2 on T cells and enhanced LFA-3 bind-56, and CD83 (Hock et al., 1994; Zhou and Tedder, 1995;
ing, thereby reinforcing the contact between DC and TAdema et al., 1997; de Saint-Vis et al., 1998). DC-SIGN
cells. Both the TCR and CD2 are, because of theircan be added to this list since both immature and mature
smaller dimensions, localized in the center of the contactmonocyte- and a subpopulation of CD341 bone mar-
whereas the larger LFA-1 and ICAM-1 molecules formrow±derived DC express DC-SIGN (Table 1; data not
a ring around this central disc (Dustin et al., 1998; Gra-shown). In situ DC-SIGN is exclusively expressed by DC
koui et al., 1999). However, in most of these elegantsubsets present in the T cell area of tonsils, lymph
studies interactions of resting T cells with the naturalnodes, and spleen (Figure 5). Thus, DC-SIGN expression
professional antigen-presenting cell, the DC, were notin situ correlates well with its function as an important
investigated. We propose a model in which the initialmediator of DC±T cell clustering and T cell activation.
interaction of DC with resting T cells is mediated byIn skin, DC-SIGN expression is found on dermal DC
DC-SIGN-ICAM-3 (Figure 6F), followed by interactionswhereas it is not expressed by CD1a1 Langerhans cells
through other adhesion molecules such as LFA-1 andin the epidermis. In mucosal tissues such as rectum,
LFA-3 that are involved in more stable DC±T cell con-uterus, and cervix, sites prone to HIV-1 exposure, DC-
tacts (Figures 6A, 6B, and 6C). We hypothesize that theSIGN is abundantly expressed by DC present in the
initial contact between DC and resting T cells mediatedlamina propria, further substantiating the importance of
by DC-SIGN/ICAM-3 transiently stabilizes the intimatethe localization of DC as a first-line defense against
DC±T cell membrane contact to provide efficient TCRviruses and pathogens (Geijtenbeek et al., 2000).
engagement (Figure 6F). The transient nature of DC-
SIGN-ICAM-3 interactions enables DC to interact with
Interactions of DC with Resting T Cells a large number of resting T cells, until productive TCR
Recognition of antigen presented by professional anti- engagement is obtained. TCR signaling alters the avidity
gen-presenting cells (DC) to T cells requires the forma- of LFA-1 and CD2, thereby strengthening the interaction
tion of a specialized junction between these cells that between DC and T cell via multiple adhesive contacts
is generated by carefully orchestrated recruitment of through LFA-1 and LFA-3 that will provide further posi-
specific receptors into the contact area (Monks et al., tional stability and full activation of the T cell by the DC
1998; Grakoui et al., 1999). It has been proposed that the (Shaw and Dustin, 1997).
first step requires low-avidity interactions of adhesion The importance of DC-SIGN/ICAM-3 interactions in
the initial DC±T cell contact is further emphasized bymolecules such as LFA-1 and CD2 present on T cells
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Brussels, Belgium) (Romani et al., 1994; Sallusto and Lanzavecchia,the potency of anti-DC-SIGN antibodies to inhibit DC-
1994). At day 7, the phenotype of the cultured DC was confirmedinduced proliferation of resting T cells but much less of
by flow cytometric analysis. The DC express high levels of MHCPHA-IL-2 activated T cells. Since, in contrast to resting
class I and II, aMb2 (CD11b), aXb2 (CD11c), and ICAM-1, moderate
T cells, activated T cells also express ICAM-1 and high levels of LFA-1 and CD86, and low levels of CD14. Peripheral blood
CD2 levels (Alberola Ila et al., 1991; Parra et al., 1993), lymphocytes (PBL) were obtained from buffy coats of healthy indi-
viduals and were purified using Ficoll density centrifugation. Trans-LFA-1/ICAM-1 and LFA-3/CD2 interactions take over
fection of COS7 was performed by DEAE dextran. Stable K562DC-SIGN/ICAM-3 interactions. This observation stresses
transfectants expressing ICAM-3 (K562-ICAM-3) were generated bythe importance of DC-SIGN in primary immune re-
cotransfection of K562 with 10 mg PCRII ICAM-3 plasmid (gift fromsponses rather than secondary responses and directly
Dr. D. Simmons) and 2 mg PGK-hyg vector (te Riele et al., 1990) by
correlates with its restricted tissue expression. electroporation as described (Lub et al., 1997).
In summary, we have identified a novel DC-specific
C-type lectin, DC-SIGN, that by binding to ICAM-3 plays Isolation and Expression of the cDNA Encoding DC-SIGN
Immunoprecipitated DC-SIGN was identified by peptide sequenc-an important role in establishing the first contact be-
ing. Tryptic digestion, purification of the resulting peptides, andtween DC and resting T cells. This interaction and subse-
sequence analysis were performed by Eurosequence BV (Gron-quent low-avidity interactions of other adhesion mole-
ingen, The Netherlands). The cDNA encoding the placenta gp120
cules enable productive TCR engagement followed by binding C-type lectin was amplified by RT-PCR on total RNA from
adhesion strengthening. Future experiments are needed DC. PCR primers were based on the nucleotide sequence of the
to determine how DC-SIGN-ICAM-3 interactions or- placenta gp120 binding C-type lectin (accession number M98457
[Curtis et al., 1992]), and the nucleotide sequences (59 to 39) are aschestrate the recruitment of adhesion molecules such
follows: XF29, AGAGTGGGGTGACATGAGTG; and XR1265, GAAGTas LFA-1 and CD2 and TCR molecules that are involved
TCTGCTACGCAGGAG. The nucleotide sequence of the clonedin the junction between antigen-presenting cells and
cDNA was identical to that of placenta gp120 binding C-type lectin
resting T cells. (Curtis et al., 1992). The cDNA was subsequently cloned into the
eukaryotic expression vector pRc/CMV (pRc/CMV-DC-SIGN). Sta-
Experimental Procedures ble THP-1 transfectants expressing DC-SIGN were generated by
transfection of THP-1 cells with pRc/CMV-DC-SIGN by electropora-
Antibodies tion similarly as was described for the generation of K562-ICAM-3.
The following mAb were used: NKI-L15 (anti-aL), AZN-L19 (anti-b2),
AIIB2 (anti-b1), CBR-IC3/1, CBR-IC3/2, 186±269 (anti-ICAM-3), RR1/1 Fluorescent Bead Adhesion Assay
(anti-ICAM-1), CD14 (WT14), MHC class I (W6/32), and MHC class Carboxylate-modified TransFluorSpheres (488/645 nm, 1.0 mm; Mo-
II (Q5/13) LFA-3 (TS2/9). Anti-DC-SIGN mAb AZN-D1 and AZN-D2 lecular Probes, Eugene, OR) were coated with ICAM-3-Fc as de-
were obtained by screening hybridoma supernatants of human DC- scribed previously (Geijtenbeek et al., 1999). The fluorescent bead
immunized BALB/c mice for the ability to block adhesion of DC to adhesion assay was performed as described by Geijtenbeek et al.
ICAM-3, as measured by the fluorescent bead adhesion assay. (1999). In brief, cells were resuspended in adhesion buffer (20 mM
Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, and 0.5%
BSA) at a final concentration of 5 3 106 cells/ml. Fifty thousandCells
Immature DC were cultured from monocytes in the presence of IL-4 cells were preincubated with mAb (20 mg/ml) for 10 min at room
temperature. Ligand-coated fluorescent beads (20 beads/cell) wereand GM-CSF (500 and 800 U/ml, respectively; Schering-Plough,
Figure 6. Transient DC-SIGN-Mediated Adhesion to ICAM-3-Expressing T Cells Is Essential in Allogeneic DC-Induced T Cell Proliferation
(A) Heterotypic cell clustering of DC with K562-ICAM-3 cells. K562 and K562 cells stable transfected with the cDNA encoding ICAM-3 (K562-
ICAM-3) were labeled with the fluorescent dye hydroethidine. DC were labeled with the fluorescent dye sulfofluorescein. K562 and K562-
ICAM-3 were incubated with DC (50 3 103 cells/cell type) with or without blocking anti-DC-SIGN antibody (AZN-D1; 20 mg/ml) at 378C. At
different time points, the heterotypic cell clustering was measured by flow cytometry. A representative experiment of two experiments is
given.
(B) Dynamic cell clustering of DC with resting T cells is mediated by DC-SIGN. DC (50 3 103 cells) were preincubated with/without the anti-
DC-SIGN antibodies (AZN-D1 and AZN-D2 [10 mg/ml] or anti-LFA-1 and anti-LFA-3 antibodies [10 mg/ml]) for 10 min at room temperature.
Allogeneic T cells (1 3 106 cells), labeled with the fluorescent dye Calcein-A, were added, and the cell mixture was incubated at 378C. The
clustering was determined by flow cytometry by measuring the percentage of DC that clustered with fluorescently labeled T cells. A representa-
tive experiment out of three is shown.
(C) DC-SIGN-ICAM-3 interactions are important in DC-induced allogeneic T cell proliferation. Allogeneic resting responder T lymphocytes
(100 3 103) were added to immature DC (1.5 3 103) with/without blocking mAb (10 mg/ml) against b2 integrins (AZN-L19), ICAM-1 (RR1/1),
ICAM-3 (186±269), LFA-3 (TS2/9), and DC-SIGN (AZN-D1, AZN-D2). The cells were cultured for 4 days and pulsed for 16 hr with [3H]methyl-
thymidine, and incorporation was determined. Syngeneic DC-induced T cell proliferation is low (,5000 cpm). The results are expressed as
the mean percent of CPM from triplicate wells. One representative experiment out of three is shown.
(D) DC-SIGN does not mediate interactions between DC and activated T cells. IL-2/PHA stimulated allogeneic responder T lymphocytes (100 3
103) were added to immature DC (1.5 3 103) with/without blocking mAb as described in Figure 6C. The cells were cultured for 4 days and
pulsed for 16 hr with [3H]methyl-thymidine, and incorporation was determined. The results are expressed as the mean percent of CPM from
triplicate wells. One representative experiment out of three is shown.
(E) Anti-DC-SIGN antibodies do not affect the DC phenotype. Immature DC were cultured for 1 day in the presence of anti-DC-SIGN antibodies
or control antibodies (10 mg/ml). Cells were analyzed for expression of anti-LFA-1, -LFA-3, -MHC class I, and -MHC class II IgG2A antibodies,
following staining with a FITC-conjugated goat anti-mouse IgG2A antibody. Cells were gated on forward and side scatter, and the mean
fluorescence is shown in the top right corner of the histograms. One representative experiment out of three is shown.
(F) Model of DC-resting T cell interactions (1). DC-SIGN/ICAM-3 interactions form a first contact between DC and T cell. This transient
interaction facilitates the formation of low-avidity interactions in which LFA-1/ICAM-1 also participates giving rise to loose antigen-independent
DC±T cell clustering (2). Only after TCR ligation (3), signals result in high-avidity LFA-1/ICAM-1 and CD2/LFA-3 interactions giving rise to a
further stabilization of the immunological synapse in which the smaller TCR/MHC/peptide and CD2/LFA-3 form the center and LFA-1/ICAM-1
form the outer ring (4).
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added, and the suspension was incubated for 30 min at 378C. Adhe- Binnerts, M.E., van Kooyk, Y., Simmons, D.L., and Figdor, C.G.
(1994). Distinct binding of T lymphocytes to ICAM-1, 22 or 23 uponsion was determined by measuring the percentage of cells, which
have bound fluorescent beads, by flow cytometry using the FAC- activation of LFA-1. Eur. J. Immunol. 24, 2155±2160.
Scan (Becton Dickinson, Oxnard, CA). Curtis, B.M., Scharnowske, S., and Watson, A.J. (1992). Sequence
and expression of a membrane-associated C-type lectin that exhib-
Heterotypic Cell Clustering and DC-Induced T Cell Proliferation its CD4-independent binding of human immunodeficiency virus en-
DC and ICAM-3-expressing cells (2 3 106 cells/ml) were labeled, velope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89, 8356±
respectively, with sulfofluorescein (Molecular Probes; 50 mg/ml) and 8360.
hydroethidine (Molecular Probes; 40 mg/ml) for 1 hr at 378C. DC Davis, S.J., and van der Merwe, P.A. (1996). The structure and ligand
and the ICAM-3-expressing cells were mixed (50 3 103 cells each) interactions of CD2: implications for T-cell function. Immunol. Today
and incubated at 378C. At different time points, the cells were fixed 17, 177±187.
with paraformaldehyde (0.5%), and heterotypic cell clustering was
de Fougerolles, A.R., and Springer, T.A. (1992). Intercellular adhe-measured by flow cytometry.
sion molecule 3, a third adhesion counter-receptor for lymphocyteClustering between DC with resting T cells was assessed by a
function-associated molecule 1 on resting lymphocytes. J. Exp.different method. DC (50 3 103 cells) were preincubated with/without
Med. 175, 185±190.the anti-DC-SIGN mAb AZN-D1 and AZN-D2 (10 mg/ml) for 10 min
Delpozo, M.A., Campanero, M.R., Sanchez-Mateos, P., Arroyo, A.G.,at room temperature. Allogeneic PBL (1 3 106 cells), labeled with
Pulido, R., Munoz, C., Hernandez-Caselles, T., Aparicio, P., andthe fluorescent dye Calcein-A (Molecular Probes); 25 mg/107cells/
Sanchez-Madrid, F. (1994). Role of ICAM-3 in intercellular adhesionml for 30 min at 378C were added and the cell mixture was incubated
and activation of T lymphocytes. Cell Adhes. Commun. 2, 211±218.at room temperature. The clustering was determined by measuring
percentage of DC that have bound fluorescent T cells by flow cytom- de Saint-Vis, B., Vincent, J., Vandenabeele, S., Vanbervliet, B., Pin,
etry. The livegate was set to contain only DC. J.J., Ait-Yahia, S., Patel, S., Mattei, M.G., Banchereau, J., Zurawski,
Resting or activated (cultured in the presence of 400 U IL-2/ml S., et al. (1998). A novel lysosome-associated membrane glycopro-
0.2 mg/ml PHA for 2 days) allogeneic responder T lymphocytes tein, DC-LAMP, induced upon DC maturation, is transiently ex-
(100 3 103) were added to DC (1.5 3 103) in the presence of blocking pressed in MHC class II compartment. Immunity 9, 325±336.
mAb (10 mg/ml). The cells were cultured for 4 days. On day 4, the Drickamer, K. (1995). Increasing diversity of animal lectin structures.
cells were pulsed for 16 hr with [3H]methyl-thymidine (1.52 TBq/ Curr. Opin. Struct. Biol. 5(5), 612±616.
mmol, 0.5 mCi/well; Amersham), and thymidine incorporation was
Drickamer, K.(1999). C-type lectin-like domains. Curr. Opin. Struct.quantified.
Biol. 9(5), 585±590.
Dustin, M.L., and Springer, T.A. (1989). T-cell receptor cross-linkingImmunohistochemical Analysis
transiently stimulates adhesiveness through LFA-1. Nature 341,Cryosections (8 m) of the tissues were fixed in 100% aceton (10
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